» Articles » PMID: 36144639

Polyphenols As Lung Cancer Chemopreventive Agents by Targeting MicroRNAs

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Sep 23
PMID 36144639
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the second leading cause of cancer-related death worldwide. In recent decades, investigators have found that microRNAs, a group of non-coding RNAs, are abnormally expressed in lung cancer, and play important roles in the initiation and progression of lung cancer. These microRNAs have been used as biomarkers and potential therapeutic targets of lung cancer. Polyphenols are natural and bioactive chemicals that are synthesized by plants, and have promising anticancer effects against several kinds of cancer, including lung cancer. Recent studies identified that polyphenols exert their anticancer effects by regulating the expression levels of microRNAs in lung cancer. Targeting microRNAs using polyphenols may provide a novel strategy for the prevention and treatment of lung cancer. In this review, we reviewed the effects of polyphenols on oncogenic and tumor-suppressive microRNAs in lung cancer. We also reviewed and discussed the potential clinical application of polyphenol-regulated microRNAs in lung cancer treatment.

Citing Articles

The role of natural products targeting macrophage polarization in sepsis-induced lung injury.

Li Y, Ai S, Li Y, Ye W, Li R, Xu X Chin Med. 2025; 20(1):19.

PMID: 39910395 PMC: 11800549. DOI: 10.1186/s13020-025-01067-4.


Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo.

Li J, Zhong X, Zhao Y, Shen J, Xiao Z, Pilapong C Sci Rep. 2024; 14(1):2348.

PMID: 38287075 PMC: 10824707. DOI: 10.1038/s41598-024-52896-6.

References
1.
Gibbons D, Lin W, Creighton C, Rizvi Z, Gregory P, Goodall G . Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 2009; 23(18):2140-51. PMC: 2751985. DOI: 10.1101/gad.1820209. View

2.
Zhang J, Zhang Y, Shen W, Fu R, Ding Z, Zhen Y . Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Biomed Pharmacother. 2019; 117:109058. DOI: 10.1016/j.biopha.2019.109058. View

3.
You J, Zhang Y, Li Y, Fang N, Liu B, Zu L . MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer. Am J Cancer Res. 2015; 5(9):2730-44. PMC: 4633902. View

4.
Zhou J, Wang H, Sun Q, Liu X, Wu Z, Wang X . miR-224-5p-enriched exosomes promote tumorigenesis by directly targeting androgen receptor in non-small cell lung cancer. Mol Ther Nucleic Acids. 2021; 23:1217-1228. PMC: 7899953. DOI: 10.1016/j.omtn.2021.01.028. View

5.
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H . Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. PLoS One. 2016; 11(4):e0153046. PMC: 4836744. DOI: 10.1371/journal.pone.0153046. View